Stopping weight-loss drugs reverses heart protection, raises attack/stroke risk

New research indicates that discontinuing popular weight-loss injections negates their cardiovascular benefits, leaving patients with elevated heart attack and stroke risk. The finding underscores the importance of continued therapy, though the study's scope and patient population remain unspecified. This could influence prescribing practices and patient adherence, with potential public-health implications.